These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 17401022)

  • 1. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
    Hammond AL; Waller EK; Finkelstein LB
    J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
    [No Abstract]   [Full Text] [Related]  

  • 2. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of geriatric principles in oncology clinical trials.
    Hurria A
    J Clin Oncol; 2007 Dec; 25(34):5350-1. PubMed ID: 18048814
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase 0 clinical studies in oncology.
    Collins JM
    Clin Pharmacol Ther; 2009 Feb; 85(2):204-7. PubMed ID: 19109589
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathology is a necessary and informative tool in oncology clinical trials.
    Nagtegaal ID; West NP; van Krieken JH; Quirke P
    J Pathol; 2014 Jan; 232(2):185-9. PubMed ID: 24037805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
    Ratain MJ; Karrison TG
    Clin Cancer Res; 2007 Feb; 13(3):781-2. PubMed ID: 17289865
    [No Abstract]   [Full Text] [Related]  

  • 7. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
    Steensma DP
    J Clin Oncol; 2007 Mar; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of genomics in clinical trial design.
    Simon R
    Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mentoring of research associates in the Southwest Oncology Group (SWOG)--quality assurance in clinical trials.
    Davis B
    J Oncol Manag; 2003; 12(2):30-1. PubMed ID: 12699114
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
    Lin DW; Shore ND
    Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
    [No Abstract]   [Full Text] [Related]  

  • 11. [Randomized clinical trials].
    Dvoĭrin VV
    Vopr Onkol; 1982; 28(4):70-2. PubMed ID: 7090274
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
    Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
    J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trials in oncology and elderly patients].
    Moncenix G
    Soins Gerontol; 2003; (44):39. PubMed ID: 14648943
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical oncologists' participation in cancer clinical trials.
    Spaight SJ; Nash S; Finison LJ; Patterson WB
    Prog Clin Biol Res; 1984; 156():49-61. PubMed ID: 6473452
    [No Abstract]   [Full Text] [Related]  

  • 15. The ethical approach to randomization in oncology.
    Arpaillange P; Dion S
    Drugs Exp Clin Res; 1986; 12(1-3):99-103. PubMed ID: 3732058
    [No Abstract]   [Full Text] [Related]  

  • 16. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research plan for radiation oncology--1987: design and analysis of clinical trials.
    Davis LW; Bauer M
    Am J Clin Oncol; 1988 Jun; 11(3):404-10. PubMed ID: 3381761
    [No Abstract]   [Full Text] [Related]  

  • 18. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to special issue on biomarker-based clinical trial designs in oncology.
    Sargent DJ; Mandrekar S; Grothey A
    Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric clinical trials: experiences of the Children's Oncology Group.
    Auger N
    Can Oncol Nurs J; 2003; 13(3):187. PubMed ID: 14508908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.